Anti-viral activity of SCH 503034, a HCV protease inhibitor, administered as monotherapy in hepatitis C genotype-1 (HCV-1) patients refractory to pegylated interferon (peg-IFN-α) - Zeuzem,S.; Sarrazin,C.; Rouzier,R. (Hepatology, 2005)